Dulaglutide Cuts Weight Gain After Smoking Cessation
By Lori Solomon HealthDay Reporter
FRIDAY, Dec. 22, 2023 -- Dulaglutide cuts post-smoking cessation weight gain in men and women, according to a study published online Dec. 19 in BMJ Nutrition, Prevention & Health.
Fabienne Baur, M.D., from University Hospital Basel in Switzerland, and colleagues investigated gender differences in weight change after dulaglutide-assisted smoking cessation. The analysis included 255 adults who smoked daily (155 women and 100 men) who were randomly assigned to weekly dulaglutide (1.5 mg) or placebo (0.9 percent sodium chloride) in addition to standardized smoking cessation care (varenicline 2 mg/day plus behavioral counseling) for 12 weeks.
The researchers observed no gender differences in absolute or relative weight change for either dulaglutide or placebo treatment. In the placebo group, substantial weight gain (>6 percent increase) was almost five times more frequent in women than men (24 versus 5 percent). On dulaglutide, female participants were less likely to have substantial weight gain versus those treated with placebo (1 versus 24 percent). This dulaglutide effect was less pronounced in men (0 versus 5 percent).
"Our results underline the efficacy of dulaglutide in preventing postcessation weight gain in both genders and particularly in women who appear to be more prone to substantial weight gain than men," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
Most Slow Responders to Tirzepatide Do Lose Clinically Meaningful Weight
TUESDAY, May 14, 2024 -- Among slow responders to tirzepatide treatment at week 12, 90 percent went on to achieve clinically meaningful weight reduction (≥5 percent) by week...
Cytisinicline Beneficial for Cessation of Electronic Cigarette Smoking
MONDAY, May 13, 2024 -- Cytisinicline for 12 weeks with behavioral support is efficacious for cessation of electronic cigarette smoking, according to a study published online May...
Metabolic Syndrome, Obesity Independently Linked to Breast Cancer
MONDAY, May 13, 2024 -- Metabolic syndrome (MetS) and obesity have independent and distinct associations with breast cancer subtypes and mortality, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.